Patents Assigned to Allarity Therapeutics Europe ApS
  • Methods for predicting drug responsiveness in cancer patients
    Patent number: 11421284
    Abstract: The present invention features methods, devices, and kits for detecting expression in a patient having cancer or determining responsive of a patient having cancer to a treatment, such as irofulven. The invention further includes methods of treating a patient having cancer by administering, e.g., irofulven.
    Type: Grant
    Filed: July 13, 2020
    Date of Patent: August 23, 2022
    Assignee: Allarity Therapeutics Europe ApS
    Inventor: Steen Knudsen